En
Da
Fr
De
Sv
Deal History
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer/E-commerce
Digital Media
Industrial Technology
Life Sciences
Software & TMT
Insights
News
Newsletter
Research
About us
Company
Team
Offices
Globalscope
Career
Events
Contact
En
Da
Fr
De
Sv
Main menu button
Team
Deals
Contact
Equity Research
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Thinc Jetty
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Corporate Finance
Equity Research
Events
In Media
M&A Know-how
Macro and markets
Market Snapshots
Uncategorized
03 Apr 2023
Mrkt BUZZ ALM Equity: New owner in Klövern and upcoming new share issues
Equity Research
ALM Equity
01 Apr 2023
Research update Zazz Energy, Q4 2022: Possible upside in the stock, but significant risk
Equity Research
Zazz Energy
31 Mar 2023
First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
Equity Research
Zazz Energy
30 Mar 2023
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
Equity Research
Risk Intelligence
29 Mar 2023
Mrkt BUZZ, Biosergen: Plans for speedy development of lead candidate
Equity Research
Biosergen
29 Mar 2023
Swedish Real Estate Equity Snapshot
Equity Research
29 Mar 2023
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
Equity Research
Carlsquare
24 Mar 2023
Carlsquare advised F2 Healthcare in its acquisition by Meduit, expanding revenue cycle solutions for Medicare Bad Debt
Corporate Finance
22 Mar 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research
Carlsquare
20 Mar 2023
Initiation of coverage, Biosergen: Make antifungals great again
Equity Research
Biosergen
20 Mar 2023
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
Equity Research
Future Gaming
15 Mar 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research
Carlsquare
15 Mar 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
Kancera
13 Mar 2023
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
Equity Research
InCoax
10 Mar 2023
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
Equity Research
InCoax
08 Mar 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research
Carlsquare
06 Mar 2023
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
Equity Research
Zinzino
06 Mar 2023
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
Equity Research
Risk Intelligence
01 Mar 2023
Carlsquare weekly market letter: Can Junk lead the way?
Equity Research
Carlsquare
28 Feb 2023
Research update ALM Equity: Write-downs in associates affect results
Equity Research
ALM Equity
1
2
3
4
5
6
…
66